Research programme: sydnocarb - In October 2011, Cephalon was acquired by Teva Pharmaceutical Industries809129787.Alternative Names: Mesocarb; Sidnocarb
Latest Information Update: 12 Apr 2010
At a glance
- Originator Cephalon
- Class Antidepressants; Antipsychotics; Carbamates; Imines; Oxadiazoles
- Mechanism of Action Dopamine uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 19 Nov 2008 Preclinical trials in Neurological disorders in USA (Intraperitoneal)